Search
Search Results
##search.searchResults.foundPlural##
-
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4950PDF: 1633HTML: 2277Untitled: 278Untitled: 298Untitled: 315Untitled: 268Untitled: 279 -
Microangiopathic Anemia of Acute Brucellosis – is it a True TTP?
1280PDF: 849HTML: 1795 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2644PDF: 1409HTML: 1852CoverLetter: 235 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
3304PDF: 1116HTML: 344Suppl. Files: 542 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3727PDF: 1629HTML: 4527CoverLetter: 256Figure1: 271 -
OUTBREAK OF BURKHOLDERIA CEPACIA INFECTION: A SYSTEMATIC STUDY IN A HEMATOLOGY-ONCOLOGY UNIT OF A TERTIARY CARE HOSPITAL FROM EASTERN INDIA.
2425PDF: 1020HTML: 522Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 269UntitOutbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern Indialed: 410Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 301Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 225Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 240Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 316 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2808PDF: 1120HTML: 5129Cover Letter: 208Figure 2: 216Figure 1: 222Figure 3: 246Figure 4: 217Figure Legend: 234Table 1: 246Table 2: 230Table 3: 225 -
A rare case of multidrug resistant Leclercia adecarboxylata catheter-related bloodstream infection and an updated brief literature review Leclercia adecarboxylata catheter-related bloodstream infection.
1027PDF: 643HTML: 227 -
Evaluating the use of meropenem in hematologic patients with febrile neutropenia A retrospective observational single-cohort study
1346PDF: 556HTML: 162 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3865PDF: 1345HTML: 3955Untitled: 287Untitled: 319 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1244PDF: 909HTML: 306 -
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
247PDF: 763HTML: 76 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
947PDF: 561HTML: 254Suppl. Files: 356 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1565PDF: 1407HTML: 122 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1590PDF: 1027HTML: 453 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2842PDF: 1039HTML: 3756 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1697PDF: 1186HTML: 276 -
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2359PDF: 1067HTML: 4991 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6513PDF: 2238HTML: 14167Untitled: 252figure: 231 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
11026PDF: 6585HTML: 21974 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
3006PDF: 1178HTML: 500Preferred Reviewers: 254 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5538PDF: 1420HTML: 2882Cover letter: 250 -
IMMUNOLOGY OF TUBERCULOSIS
5909PDF: 2349HTML: 7372Untitled: 251 -
Pseudo-differentiation syndrome
1531PDF: 731HTML: 10888Figure 1: peripheral blood showing myeloblasts with auer rods: 163Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 147Figure 3: CXR showing pulmonary infiltartes with consolidation: 169Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 154Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 150 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1612PDF: 864Suppl. Files: 368Html: 170 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4543PDF: 993HTML: 1370Table1: 259 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3559PDF: 1339HTML: 8418







